Abstract:Owing to inconsistent results in analyses between blood cadmium levels and depressive symptoms, we cannot conclude any solid association between blood cadmium levels and depressive symptoms in the elderly population. To clarify the relationship, other prospective studies are needed in the future.
“…In support of this decision, mean blood cotinine level in non-smokers is 10.93 ng/ml in our study, suggesting that it is present in nonsmokers and is important to include in the model. Another recent study of 395 elderly (age > 60) people living in Seoul, South Korea, also found a positive association between BCd and depressive symptoms, and while they did attempt to stratify by smoking status, they had very few current (23 people) and former (24) smokers in their sample (Han et al, 2016). Taken as a whole, these studies generally controlled for urine or serum cotinine, a sensitive and specific biomarker of current tobacco exposure (Bramer and Kallungal, 2003) but they did not control for pack-years, an indicator of long-term smoking exposure.…”
Section: Discussionmentioning
confidence: 97%
“…Although recent studies that have shown a link between BCd and depressive symptoms did adjust for smoking (Berk et al, 2014; Han et al, 2016; Scinicariello and Buser, 2015), their models may still have been susceptible to residual confounding. The Berk et al (2014) study using NHANES 2005–2010- the same population as our study - found an association between BCd and depressive symptoms, defined like our study as PHQ-9 score ≥ 10, for the upper quartile of BCd (OR 1.48 95% CI 1.16–1.90).…”
Section: Discussionmentioning
confidence: 99%
“…It has been associated with various psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder (Mendez-Armenta and Rios, 2007; Olabanji, 2011; Orisakwe, 2014). In particular, previous studies have shown a positive association between elevated blood cadmium (BCd) levels and depressive symptoms (Berk et al, 2014; Han et al, 2016; Scinicariello and Buser, 2015). The link between urine cadmium (UCd) levels and depressive symptoms is less clear (Shiue, 2015)-possibly due to the fact that BCd is more indicative of short term mixed with long-term exposure and UCd is more representative of lifetime exposure (Jarup et al, 1998).…”
Our aim was to explore the association between blood cadmium (BCd) and depressive symptoms, adjusting for pack years and blood cotinine, and also stratifying by smoking status. Using data from the US National Health and Nutrition Examination Survey (NHANES) 2005–2012, we categorized depressive symptoms using the PHQ-9 (Patient Health Questionnaire-9) survey and modeled depressive symptoms in relation to BCd adjusted for blood cotinine, pack years of smoking, and other covariates. We also stratified by self-reported smoking status (current, former, never). There were 11,209 subjects from 2005 to 2012, age ≥ 18 with PHQ-9, smoking, and blood cadmium data available. 876 (7.8%) met criteria for depressive symptoms. Depressive symptoms were associated with BCd levels in a crude model and with adjustment for pack years and cotinine. The association disappeared when analyzed among current, former, or never smokers. Consistent with the literature, we found an association between BCd and depressive symptoms; however, that association disappears in analyses strati-fied by smoking status. This suggests residual confounding may be present. It is important to stratify by smoking status when investigating health outcomes associated with BCd.
“…In support of this decision, mean blood cotinine level in non-smokers is 10.93 ng/ml in our study, suggesting that it is present in nonsmokers and is important to include in the model. Another recent study of 395 elderly (age > 60) people living in Seoul, South Korea, also found a positive association between BCd and depressive symptoms, and while they did attempt to stratify by smoking status, they had very few current (23 people) and former (24) smokers in their sample (Han et al, 2016). Taken as a whole, these studies generally controlled for urine or serum cotinine, a sensitive and specific biomarker of current tobacco exposure (Bramer and Kallungal, 2003) but they did not control for pack-years, an indicator of long-term smoking exposure.…”
Section: Discussionmentioning
confidence: 97%
“…Although recent studies that have shown a link between BCd and depressive symptoms did adjust for smoking (Berk et al, 2014; Han et al, 2016; Scinicariello and Buser, 2015), their models may still have been susceptible to residual confounding. The Berk et al (2014) study using NHANES 2005–2010- the same population as our study - found an association between BCd and depressive symptoms, defined like our study as PHQ-9 score ≥ 10, for the upper quartile of BCd (OR 1.48 95% CI 1.16–1.90).…”
Section: Discussionmentioning
confidence: 99%
“…It has been associated with various psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder (Mendez-Armenta and Rios, 2007; Olabanji, 2011; Orisakwe, 2014). In particular, previous studies have shown a positive association between elevated blood cadmium (BCd) levels and depressive symptoms (Berk et al, 2014; Han et al, 2016; Scinicariello and Buser, 2015). The link between urine cadmium (UCd) levels and depressive symptoms is less clear (Shiue, 2015)-possibly due to the fact that BCd is more indicative of short term mixed with long-term exposure and UCd is more representative of lifetime exposure (Jarup et al, 1998).…”
Our aim was to explore the association between blood cadmium (BCd) and depressive symptoms, adjusting for pack years and blood cotinine, and also stratifying by smoking status. Using data from the US National Health and Nutrition Examination Survey (NHANES) 2005–2012, we categorized depressive symptoms using the PHQ-9 (Patient Health Questionnaire-9) survey and modeled depressive symptoms in relation to BCd adjusted for blood cotinine, pack years of smoking, and other covariates. We also stratified by self-reported smoking status (current, former, never). There were 11,209 subjects from 2005 to 2012, age ≥ 18 with PHQ-9, smoking, and blood cadmium data available. 876 (7.8%) met criteria for depressive symptoms. Depressive symptoms were associated with BCd levels in a crude model and with adjustment for pack years and cotinine. The association disappeared when analyzed among current, former, or never smokers. Consistent with the literature, we found an association between BCd and depressive symptoms; however, that association disappears in analyses strati-fied by smoking status. This suggests residual confounding may be present. It is important to stratify by smoking status when investigating health outcomes associated with BCd.
“…We thank Dr Tomoyuki Kawada1 for his interest in our manuscript entitled ‘Does cadmium exposure contribute to depressive symptoms in the elderly population?’2 In the letter, Dr Kawada depicted three possible reasons for the inconsistent results of our study: limited statistical power, use of blood cadmium as marker of cadmium exposure and the presence of other potential confounding variables.…”
“…Han et al 1 investigated the association between blood cadmium levels (B-Cd) and depression in 395 people, aged 60 years or older. Survey was conducted three times, and positive association between B-Cd and depression was only observed in the first visit.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.